HCA (HCA) Q1 2026 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool

Fri, April 24, 2026 astatine 10:46 AM CDT 41 min read

Image source: The Motley Fool.

April 24, 2026

• Chief Executive Officer — Sam Hazen

• Chief Financial Officer — Mike Marks

• Investor Relations — Frank Morgan

Sam Hazen: Good morning, and convey you for joining the call. First, I privation to admit our colleagues for continuing to show a singular quality to accommodate to changing conditions and present affirmative results for our patients, communities, and stakeholders. The commencement of the twelvemonth presented a dynamic situation for HCA Healthcare, Inc. From a measurement perspective, we did not acquisition the emblematic assistance related to seasonal respiratory conditions. Compared to the archetypal 4th of past year, our respiratory-related admissions were down 42%, and our respiratory-related exigency country visits were down 32%. Additionally, the tempest that deed a fewer of our markets adversely impacted our volumes successful the quarter.

On the affirmative side, however, we experienced a greater nett payment than anticipated from authorities supplemental programs. As a reminder, these programs are complex, variable, and hard to predict. This payment mostly offset the interaction from the shortfall successful volumes. Regarding payer premix for the quarter, the underlying shifts resulting from the changes successful the wellness security exchanges were mostly successful enactment with our expectations. This country remains fluid. As we stated connected our 4th fourth call, we person considered a scope of imaginable scenarios arsenic the effects proceed to evolve.

As mentioned implicit the past respective quarters, our teams person been focused connected a wide resiliency program designed to make outgo savings wherever appropriate, heighten web execution, and fortify organizational capabilities. I americium pleased with our resiliency efforts to date, and we expect they volition proceed to assistance offset immoderate of the expected interaction from the payer premix shift. Additionally, we were pleased with the measurement results exiting the quarter. The respiratory-related and wintertime tempest impacts were mostly contained to January, with February and March volumes rebounding nicely. For the archetypal quarter, gross accrued 4.3% compared to the archetypal 4th past year, adjusted EBITDA accrued astir 2%, and diluted net per share, arsenic adjusted, accrued 11% versus the prior-year period.

We proceed to present for our patients successful important metrics including improved prime measures, accrued diligent satisfaction, and simplification successful mean magnitude of stay. I stay excited astir our integer translation programme and AI agenda. They progressed during the 4th with rollout of immoderate cardinal initiatives to much facilities. Our objective teams proceed to beforehand efforts to heighten quality, safety, and services to our patients with advancement connected wide initiatives crossed nursing care, hospital-based doc services, and enactment functions. We proceed to put importantly successful web improvement with our superior spending and with selective outpatient installation acquisitions.